Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-Commentary

Mult Scler. 2022 Apr;28(5):695-696. doi: 10.1177/13524585211067708.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cell Count
  • Drug Administration Schedule
  • Humans
  • Multiple Sclerosis* / drug therapy